95 related articles for article (PubMed ID: 26913729)
1. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease.
Reddy A; Chand G; Mayilvaganan S
World J Surg; 2017 Jan; 41(1):333. PubMed ID: 26913729
[No Abstract] [Full Text] [Related]
2. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease.
Huang SM; Liao WT; Lin CF; Sun HS; Chow NH
World J Surg; 2016 Mar; 40(3):505-9. PubMed ID: 26546192
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease: Reply.
Huang SM
World J Surg; 2017 Jan; 41(1):334. PubMed ID: 27189073
[No Abstract] [Full Text] [Related]
4. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease.
Erbil Y; Ozluk Y; Giriş M; Salmaslioglu A; Issever H; Barbaros U; Kapran Y; Ozarmağan S; Tezelman S
J Clin Endocrinol Metab; 2007 Jun; 92(6):2182-9. PubMed ID: 17389702
[TBL] [Abstract][Full Text] [Related]
5. Utility of colour Doppler sonography in patients with Graves' disease.
Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Rayudu BR; Modi KD
West Indian Med J; 2009 Dec; 58(6):566-70. PubMed ID: 20583684
[TBL] [Abstract][Full Text] [Related]
6. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
[TBL] [Abstract][Full Text] [Related]
7. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
[TBL] [Abstract][Full Text] [Related]
8. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative management of patients with Graves' disease.
Chen H
Surgery; 2008 Feb; 143(2):292-3. PubMed ID: 18242347
[No Abstract] [Full Text] [Related]
10. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y
Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
Kasagi K; Hidaka A; Misaki T; Miyamoto S; Takeuchi R; Sakahara H; Sasayama S; Iida Y; Konishi J
J Nucl Med; 1994 May; 35(5):811-7. PubMed ID: 8176463
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
[TBL] [Abstract][Full Text] [Related]
14. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism.
Chang DC; Wheeler MH; Woodcock JP; Curley I; Lazarus JR; Fung H; John R; Hall R; McGregor AM
Surgery; 1987 Dec; 102(6):1055-61. PubMed ID: 3317958
[TBL] [Abstract][Full Text] [Related]
15. The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease.
Erbil Y; Giriş M; Salmaslioglu A; Ozluk Y; Barbaros U; Yanik BT; Kapran Y; Abbasoglu SD; Ozarmagan S
Surgery; 2008 Feb; 143(2):216-25. PubMed ID: 18242338
[TBL] [Abstract][Full Text] [Related]
16. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
[TBL] [Abstract][Full Text] [Related]
17. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
[TBL] [Abstract][Full Text] [Related]
18. Arterial embolization: a novel approach to thyroid ablative therapy for Graves' disease.
Xiao H; Zhuang W; Wang S; Yu B; Chen G; Zhou M; Wong NC
J Clin Endocrinol Metab; 2002 Aug; 87(8):3583-9. PubMed ID: 12161479
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease.
Li J; Zhang J; Bai Y; Cheng Y; Cai S; Sun H
Chin Med Sci J; 1994 Jun; 9(2):104-7. PubMed ID: 8000055
[TBL] [Abstract][Full Text] [Related]
20. Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?
Laurberg P
Eur J Endocrinol; 2006 Dec; 155(6):783-6. PubMed ID: 17132745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
